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This 204-page paperback text 
outlines the new chronic kidney 
disease (CKD) guideline from the 
National Collaborating Centre for 
Chronic Conditions (NCC-CC), 
commissioned by the United King-
dom’s National Health Service and 
funded by the respected National 
Institute for Health and Clinical 
Excellence (NICE). The book is 
organized into 13 chapters, with 
chapters 1–3 describing the devel-
opment of the guideline, and chap-
ters 4–15 each outlining a specific 
part of the guideline on subjects 
such as CKD identification, CKD 
progression, referral criteria, and 
management of anemia, renal bone 
disease, and cardiovascular disease. 
The recommendations are based on 
a methodical and thorough review 
of the published literature where 
available and on expert opinion of 
the guideline development group 
in areas where studies are lack-
ing. Chapter 3 summarizes the key 
points of the guideline and includes 
figures portraying algorithms for 
identifying and treating patients 
with CKD. Each of the remaining 
chapters follows the same outline. 
Beginning with a title that iden-
tifies the clinical question being 
addressed, each chapter is then 
divided into the following sections: 
Clinical Introduction, which pro-
vides an overview of the question; 
Methodology, in which the authors 
review the various studies address-
ing the particular clinical question; 
Health Economics Methodology, 
in which the authors review any 
cost-effectiveness studies; Evidence 
Statements, in which the authors 
detail specific data relevant to the 
chapter topic; From Evidence to 
Recommendations, in which the 
authors describe how they have 
used the evidence they have pre-
sented in the chapter to form the 
recommendations; and finally, 
Recommendations, in which the 
authors outline the specific recom-
mendations. In the Evidence State-
ments section, the data described 
are graded by level of evidence, 
from level 1++ for high-quality 
meta-analyses, systematic reviews 
of randomized controlled trials, or 
randomized controlled trials with 
a very low risk of bias, to level 4 for 
expert opinion as outlined in the 
NICE guideline manual. Particu-
lar strengths of this text include the 
consistent layout of each chapter, 
which has resulted in a clear outline 
of the evidence behind each recom-
mendation, as well as the attempt to 
include a cost-effectiveness analy-
sis where data are available. In the 
preface, Dr. Higgins, the director of 
the NCC-CC, writes, “The Depart-
ment of Health, in commissioning 
this guideline, was clear that the 
focus was to be on early detection 
and management… The key prior-
ity recommendations singled out in 
the guideline reflect this emphasis. 
They present clear criteria for test-
ing for CKD, suspecting progres-
sive CKD, and referring people for 
specialist assessment, all of which 
should be useful in primary care.” 
The text includes a glossary and a 
valuable list of references on which 
the guideline is based. The chapters 
also include tables that summarize 
the available evidence for each 
recommendation with the associ-
ated reference number. This text 
would be useful to primary-care 
practitioners who want to read 
more about CKD clinical practice 
guidelines. For nephrologists, the 
text would be invaluable not only 
for learning about the specific rec-
ommendations but also for under-
standing the data on which the 
guidelines are based.
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